Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H van de Waterbeemd

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The Journal of Pharmacy and Pharmacology|October 1, 1987
L-dopa esters as potential prodrugs: effect on brain concentration of dopamine metabolites in reserpinized miceD R Cooper, C Marrel, H van de Waterbeemd, et al.
The Journal of Pharmacy and Pharmacology|August 1, 1987
L-dopa esters as potential prodrugs: behavioural activity in experimental models of Parkinson's diseaseD R Cooper, C Marrel, H van de Waterbeemd, et al.
Biochemical Pharmacology|December 1, 1987
Do thermodynamic studies provide information on both the binding to and the activation of dopaminergic and other receptors?B Testa, P Jenner, G J Kilpatrick, et al.
Molecular Pharmacology|September 1, 1986
The thermodynamics of agonist and antagonist binding to dopamine D-2 receptorsG J Kilpatrick, N el Tayar, H Van de Waterbeemd, et al.
Clinical Neuropharmacology|January 1, 1984
L-Dopa methyl ester--a candidate for chronic systemic delivery of L-Dopa in Parkinson's diseaseD R Cooper, C Marrel, B Testa, et al.
The Journal of Pharmacy and Pharmacology|June 1, 1983
Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the ratS Fleminger, H van de Waterbeemd, N M Rupniak, et al.
Journal of Medicinal Chemistry|January 1, 1989
Stereoelectronic study of zetidoline, a dopamine D2 receptor antagonistS Collin, G Evrard, D P Vercauteren, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1987
The influence of aromatic substituents on the binding of substituted benzamides to dopamine D-2 receptors: congruent QSAR and MEP analysesB Testa, N el Tayar, P A Carrupt, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Journal of Pharmacy and Pharmacology|October 1, 1987
L-dopa esters as potential prodrugs: effect on brain concentration of dopamine metabolites in reserpinized miceD R Cooper, C Marrel, H van de Waterbeemd, et al.
The Journal of Pharmacy and Pharmacology|August 1, 1987
L-dopa esters as potential prodrugs: behavioural activity in experimental models of Parkinson's diseaseD R Cooper, C Marrel, H van de Waterbeemd, et al.
Biochemical Pharmacology|December 1, 1987
Do thermodynamic studies provide information on both the binding to and the activation of dopaminergic and other receptors?B Testa, P Jenner, G J Kilpatrick, et al.
Molecular Pharmacology|September 1, 1986
The thermodynamics of agonist and antagonist binding to dopamine D-2 receptorsG J Kilpatrick, N el Tayar, H Van de Waterbeemd, et al.
Clinical Neuropharmacology|January 1, 1984
L-Dopa methyl ester--a candidate for chronic systemic delivery of L-Dopa in Parkinson's diseaseD R Cooper, C Marrel, B Testa, et al.
The Journal of Pharmacy and Pharmacology|June 1, 1983
Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the ratS Fleminger, H van de Waterbeemd, N M Rupniak, et al.
Journal of Medicinal Chemistry|January 1, 1989
Stereoelectronic study of zetidoline, a dopamine D2 receptor antagonistS Collin, G Evrard, D P Vercauteren, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1987
The influence of aromatic substituents on the binding of substituted benzamides to dopamine D-2 receptors: congruent QSAR and MEP analysesB Testa, N el Tayar, P A Carrupt, et al.
Pageof 4